SCHEMBL9958705

SCHEMBL9958705

O=C(NO)C1C(=O)N(O)C(=O)c2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 7/20 0.62
HDAC7 Q8WUI4 7/20 0.62
HDAC5 Q9UQL6 7/20 0.62
HDAC3 O15379 5/20 0.62
HDAC8 Q9BY41 5/20 0.62
HDAC6 Q9UBN7 5/20 0.62
HDAC9 Q9UKV0 5/20 0.62
NCOR2 Q9Y618 1/20 0.62
HDAC1 Q13547 3/20 0.45
HDAC2 Q92769 3/20 0.45
HDAC10 Q969S8 3/20 0.45
HDAC11 Q96DB2 3/20 0.45
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TSHR P16473 2/20 0.36
LMNA P02545 2/20 0.36
RNASEH1 O60930 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19380274 0.86 HDAC4 (0.44) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL31653962 0.84 MEN1 (0.47) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL10153609 0.84 MEN1 (0.47) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL10153606 0.82 KCNA5 (0.48) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL10154010 0.82 MAPT (0.44) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL31653994 0.82 KCNA5 (0.48) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL11789850 0.82 ALDH1A1 (0.43) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL9952800 0.81 ATM (0.42) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL10153604 0.80 KCNA5 (0.47) HDAC4HDAC7HDAC5HDAC3HDAC8
SCHEMBL9953442 0.80 KCNA5 (0.53) ALDH1A1LMNASMN1; SMN2POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed